[1]
V. Topić Vučenović, “The Utilisation of population pharmacokinetic-pharmacodynamic modelling in dosing individualisation: the example of radioactive iodine 131I in the treatment of benign thyroid diseases”, arhfarm, vol. 72, no. Suppl. 4, pp. S30-S31, Oct. 2022, Accessed: Nov. 19, 2026. Available: https://test.aseestant.ceon.rs/index.php/arhfarm/article/view/38483